Christopher G. Clement files SEC Form 4 disclosures for SAVIENT PHARMACEUTICALS INC. They have made 6 open-market trades across 2 companies since 2006, most recently 2015-12-04.
CIK 0001218808
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2013, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DARA | BUY | 2013-06-03 | 2013-06-04 | $0.71 | $10K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2008-12-09 | 2008-12-10 | $4.69 | $44K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2008-04-14 | 2008-04-16 | $19.06 | $144K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2008-02-15 | 2008-02-20 | $20.00 | $222K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-15 | 2008-01-17 | $20.96 | $314K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-10 | 2008-01-14 | $22.02 | $330K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-08 | 2008-01-09 | $23.21 | $74K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-07 | 2008-01-17 | $22.68 | $340K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-02 | 2008-01-04 | $24.09 | $241K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2007-12-10 | 2007-12-12 | $15.26 | $171K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2007-04-12 | 2007-04-16 | $12.00 | $91K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2007-03-05 | 2007-03-07 | $12.59 | $431K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2007-02-15 | 2007-02-20 | $14.49 | $110K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2006-04-12 | 2006-04-13 | $5.87 | $61K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.